Fora Capital, LLC Axonics, Inc. Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $221,581 - $298,652	3,823 New	3,823 $269,000
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $337,141 - $447,890	-5,694 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $182,434 - $237,495	3,550 Added 165.58%	5,694 $361 Million
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $28,206 - $34,376	-574 Reduced 21.12%	2,144 $128 Million
Q4 2020 Feb 12, 2021	BUY	$42.19 - $51.5 $51,640 - $63,036	1,224 Added 81.93%	2,718 $135,000

Q3 2020 Nov 13, 2020	BUY	$35.33 - $51.04 $52,783 - $76,253	1,494 New	1,494 $76 Million

4.99M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.